Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)

PURPOSE: To report on the late toxicity and local control (LC) of head and neck cancer patients treated with adaptive FDG-PET/CT response-guided radiotherapy (ADMIRE) with dose escalation (NCT03376386). MATERIALS AND METHODS: Between December 2017 and April 2019, 20 patients with stage II-IV squamou...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mamgani, Abrahim, Kessels, Rob, Gouw, Zeno A.R., Navran, Arash, Mohan, Vineet, van de Kamer, Jeroen B., Sonke, Jan-Jakob, Vogel, Wouter V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518442/
https://www.ncbi.nlm.nih.gov/pubmed/37753461
http://dx.doi.org/10.1016/j.ctro.2023.100676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518442/
https://www.ncbi.nlm.nih.gov/pubmed/37753461
http://dx.doi.org/10.1016/j.ctro.2023.100676

Ejemplares similares